Back to Search Start Over

Reversible epigenetic alterations regulate class I HLA loss in prostate cancer

Authors :
Tamara S. Rodems
Erika Heninger
Charlotte N. Stahlfeld
Cole S. Gilsdorf
Kristin N. Carlson
Madison R. Kircher
Anupama Singh
Timothy E. G. Krueger
David J. Beebe
David F. Jarrard
Douglas G. McNeel
Michael C. Haffner
Joshua M. Lang
Source :
Communications Biology, Vol 5, Iss 1, Pp 1-16 (2022)
Publication Year :
2022
Publisher :
Nature Portfolio, 2022.

Abstract

Loss of HLA-I gene expression in prostate cancer is associated with repressive chromatin states, which can be reversed by pharmacological DNMT and HDAC inhibition leading to increased activation of co-cultured tumor-specific CD8+ T-cells.

Subjects

Subjects :
Biology (General)
QH301-705.5

Details

Language :
English
ISSN :
23993642
Volume :
5
Issue :
1
Database :
Directory of Open Access Journals
Journal :
Communications Biology
Publication Type :
Academic Journal
Accession number :
edsdoj.1153e9cc0b6a481e85909d4a3f28af7d
Document Type :
article
Full Text :
https://doi.org/10.1038/s42003-022-03843-6